NRSN NeuroSense Therapeutics Ltd.
Nasdaq · SEC CIK 1875091 · EDGAR
- Bought, last 12 months
- $400.0K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 5 since 2026-03-30, latest 2026-06-17 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ben-Noon Alon | CEO | $200.0K | — |
| Eisenberg Or | CFO | $200.0K | — |
| Russek-Blum Niva | CTO | — | — |
| Binder Hagit | General Manager | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 16:30 | 2026-06-16 | NRSN | Eisenberg Or | CFO | P - Purchase | $0.8 | +250.0K | 1.50M | +20% | +$200.0K | |
| 2026-06-17 16:30 | 2026-06-16 | NRSN | Ben-Noon Alon | CEO | P - Purchase | $0.8 | +250.0K | 4.53M | +6% | +$200.0K | |
| 2026-04-01 16:26 | 2026-03-26 | NRSN | Eisenberg Or | CFO | A - Grant | $0.00 | +200.0K | 1.25M | +19% | $0 | |
| 2026-03-30 | 2026-03-26 | NRSN | Binder Hagit | General Manager | A - Grant | $0.00 | +200.0K | 521.8K | +62% | $0 | |
| 2026-03-30 | 2026-03-26 | NRSN | Russek-Blum Niva | CTO | A - Grant | $0.00 | +200.0K | 468.0K | +75% | $0 |
Purchase Sale Sale after option exercise All abbreviations